Cargando…

Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction

By adapting to the actual patient anatomy during treatment, tracked multi-leaf collimator (MLC) treatment deliveries offer an opportunity for margin reduction and healthy tissue sparing. This is assumed to be especially relevant for hypofractionated protocols in which intrafractional motion does not...

Descripción completa

Detalles Bibliográficos
Autores principales: Fast, M F, Kamerling, C P, Ziegenhein, P, Menten, M J, Bedford, J L, Nill, S, Oelfke, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOP Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390952/
https://www.ncbi.nlm.nih.gov/pubmed/26816273
http://dx.doi.org/10.1088/0031-9155/61/4/1546
_version_ 1782521553802493952
author Fast, M F
Kamerling, C P
Ziegenhein, P
Menten, M J
Bedford, J L
Nill, S
Oelfke, U
author_facet Fast, M F
Kamerling, C P
Ziegenhein, P
Menten, M J
Bedford, J L
Nill, S
Oelfke, U
author_sort Fast, M F
collection PubMed
description By adapting to the actual patient anatomy during treatment, tracked multi-leaf collimator (MLC) treatment deliveries offer an opportunity for margin reduction and healthy tissue sparing. This is assumed to be especially relevant for hypofractionated protocols in which intrafractional motion does not easily average out. In order to confidently deliver tracked treatments with potentially reduced margins, it is necessary to monitor not only the patient anatomy but also the actually delivered dose during irradiation. In this study, we present a novel real-time online dose reconstruction tool which calculates actually delivered dose based on pre-calculated dose influence data in less than 10 ms at a rate of 25 Hz. Using this tool we investigate the impact of clinical target volume (CTV) to planning target volume (PTV) margins on CTV coverage and organ-at-risk dose. On our research linear accelerator, a set of four different CTV-to-PTV margins were tested for three patient cases subject to four different motion conditions. Based on this data, we can conclude that tracking eliminates dose cold spots which can occur in the CTV during conventional deliveries even for the smallest CTV-to-PTV margin of 1 mm. Changes of organ-at-risk dose do occur frequently during MLC tracking and are not negligible in some cases. Intrafractional dose reconstruction is expected to become an important element in any attempt of re-planning the treatment plan during the delivery based on the observed anatomy of the day.
format Online
Article
Text
id pubmed-5390952
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher IOP Publishing
record_format MEDLINE/PubMed
spelling pubmed-53909522017-04-27 Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction Fast, M F Kamerling, C P Ziegenhein, P Menten, M J Bedford, J L Nill, S Oelfke, U Phys Med Biol Paper By adapting to the actual patient anatomy during treatment, tracked multi-leaf collimator (MLC) treatment deliveries offer an opportunity for margin reduction and healthy tissue sparing. This is assumed to be especially relevant for hypofractionated protocols in which intrafractional motion does not easily average out. In order to confidently deliver tracked treatments with potentially reduced margins, it is necessary to monitor not only the patient anatomy but also the actually delivered dose during irradiation. In this study, we present a novel real-time online dose reconstruction tool which calculates actually delivered dose based on pre-calculated dose influence data in less than 10 ms at a rate of 25 Hz. Using this tool we investigate the impact of clinical target volume (CTV) to planning target volume (PTV) margins on CTV coverage and organ-at-risk dose. On our research linear accelerator, a set of four different CTV-to-PTV margins were tested for three patient cases subject to four different motion conditions. Based on this data, we can conclude that tracking eliminates dose cold spots which can occur in the CTV during conventional deliveries even for the smallest CTV-to-PTV margin of 1 mm. Changes of organ-at-risk dose do occur frequently during MLC tracking and are not negligible in some cases. Intrafractional dose reconstruction is expected to become an important element in any attempt of re-planning the treatment plan during the delivery based on the observed anatomy of the day. IOP Publishing 2016-02-21 2016-01-27 /pmc/articles/PMC5390952/ /pubmed/26816273 http://dx.doi.org/10.1088/0031-9155/61/4/1546 Text en © 2016 Institute of Physics and Engineering in Medicine http://creativecommons.org/licenses/by/3.0/ Original content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence (http://creativecommons.org/licenses/by/3.0) . Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.
spellingShingle Paper
Fast, M F
Kamerling, C P
Ziegenhein, P
Menten, M J
Bedford, J L
Nill, S
Oelfke, U
Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
title Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
title_full Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
title_fullStr Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
title_full_unstemmed Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
title_short Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
title_sort assessment of mlc tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390952/
https://www.ncbi.nlm.nih.gov/pubmed/26816273
http://dx.doi.org/10.1088/0031-9155/61/4/1546
work_keys_str_mv AT fastmf assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction
AT kamerlingcp assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction
AT ziegenheinp assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction
AT mentenmj assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction
AT bedfordjl assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction
AT nills assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction
AT oelfkeu assessmentofmlctrackingperformanceduringhypofractionatedprostateradiotherapyusingrealtimedosereconstruction